Most of the top research and development executives across the biopharma industry are earning around $7M a year. One would think that this list would correspond […]
Facing thousands of state and local civil lawsuits, opioid makers are scrambling to sign a deal to escape the multibillion-dollar consequences. However, they may soon have […]
To confront rising insulin prices this year, Eli Lilly introduced a generic version of its Humalog priced at half the cost. Now the company is investing […]
Fujifilm is continuing its aggressive expansion efforts with a major investment in its U.S. gene therapy operation by making a $120M addition to its Texas facilities. […]
Aiming to become the first fully VR-based hospital in the world, Israel’s Sheba Medical Center is incorporating virtual reality throughout each of its hospital departments, including […]
Of more than $3B recovered by the federal government in fiscal year 2019 from fraud and false claims, 87% involved the healthcare industry, announced the Department […]
With new Commissioner Stephen Hahn at the lead, the FDA faces several important pressures as it kicks off the year. From not erecting too many barriers […]
Solid Biosciences is laying off about 37 of its 111 employees, including Chief Operating Officer Alvaro Amorrortu and Chief Medical Officer Jorge Quiroz. The company is […]